Wegovy vs Ozempic: Semaglutide Effectiveness Explained

Last reviewed: June 4, 2026

Last updated: June 4, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Both Wegovy and Ozempic deliver semaglutide—a GLP-1 receptor agonist that slows stomach emptying and reduces appetite signals in the brain. Clinical trials show semaglutide users lose an average of 10-15% of body weight over 68 weeks. The key difference lies in pricing, prescription approval pathways, and whether PlexusDx compounded alternatives fit your health goals and budget.

Understanding Semaglutide: How Wegovy and Ozempic Compare

Wegovy and Ozempic are brand-name versions of the same medication: semaglutide. Ozempic was originally approved by the FDA for type 2 diabetes at lower doses, while Wegovy received approval specifically for weight management at higher doses. Despite their different brand names and initial uses, the underlying compound and mechanism are identical—both bind to GLP-1 receptors to regulate blood sugar, slow digestion, and suppress hunger hormones.

The practical difference comes down to dose escalation and cost. Ozempic typically maxes out at 1.0 mg weekly for diabetes, whereas Wegovy goes up to 2.4 mg weekly for weight loss. Many patients and providers use Ozempic off-label for weight management because it costs less, but Wegovy's higher therapeutic doses produce superior weight-loss outcomes in published trials. PlexusDx compounded semaglutide injection offers the same pharmacological action at a more accessible price point, starting at $149 per month with no flat per-compound pricing tiers.

Clinical Evidence: Semaglutide Weight Loss Results

The STEP 4 trial, which evaluated semaglutide 2.4 mg weekly for weight management in adults without diabetes, demonstrated mean weight loss of 17.4% compared to 2.7% in the placebo group over 68 weeks. Participants achieved significant reductions in waist circumference, improved cardiovascular markers, and reported better overall quality of life. These results apply equally to both Wegovy and compounded semaglutide formulations because the active molecule is identical—the difference is manufacturing source and retail price, not efficacy.

Real-world data shows that semaglutide works best when combined with structured lifestyle modifications: sustained calorie deficit, regular physical activity, and behavioral support. Users typically experience appetite suppression within 2-4 weeks, with continued weight loss accelerating through months 4-6 as the dose reaches therapeutic levels. Individual response varies based on metabolism, genetics, and adherence, which is why PlexusDx offers the optional Precision Peptide Genetic Test to identify your GLP-1 pathway variants and predict responsiveness before starting treatment.

Cost Comparison: Brand-Name vs. Compounded Semaglutide

Brand-name Wegovy typically costs $1,300-$1,500 per month without insurance, or $250-$550 monthly with copay assistance programs—both significantly higher than compounded alternatives. Ozempic prescribed off-label for weight loss costs $900-$1,200 monthly, though many insurance plans will not cover off-label use. PlexusDx compounded semaglutide injection starts at $149 per month across all commitment tiers, with no surprise increases as your dose increases—the pricing philosophy is simple: your dose may need to go up, your price won't.

PlexusDx compounds semaglutide through licensed 503A compounding pharmacies, ensuring pharmaceutical-grade quality, potency testing, and regulatory compliance. No membership fees, no insurance required, and HSA/FSA eligibility make compounded semaglutide accessible to patients who cannot afford brand-name alternatives or lack insurance coverage. When you factor in the optional Precision Peptide Genetic Test ($99 after first month), you gain personalized insights into your GLP-1 and GIPR receptor variants—information that brand-name prescribers rarely offer and that predicts your likelihood of strong response.

Which Semaglutide Option Is Right for You?

Choose brand-name Wegovy if your insurance covers it and copays fit your budget, or if you prefer the convenience of a retail pharmacy and brand guarantee. Choose brand-name Ozempic if your doctor recommends it for diabetes control and you pursue weight loss as a secondary benefit. Choose PlexusDx compounded semaglutide if cost is a barrier, you want nationwide availability without insurance hassles, or you're interested in genetic testing to optimize your protocol based on your peptide pathways.

Your eligibility and best fit depend on your insurance status, budget, medical history, and preference for clinical monitoring. All three options—Wegovy, Ozempic, and PlexusDx compounded semaglutide—deliver the same active ingredient and produce similar weight-loss outcomes when dosed appropriately and combined with lifestyle changes. PlexusDx supports all 50 states and offers telemedicine consultations to help you determine whether semaglutide injection, oral semaglutide, or an alternative GLP-1 compound best matches your health goals and financial situation. Start with the Precision Peptide Genetic Test in your second month to refine dosing and timing based on your genetic predispositions.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is compounded semaglutide as effective as Wegovy or Ozempic?

Yes. Compounded semaglutide from licensed 503A pharmacies contains the identical active ingredient and delivers the same clinical results as brand-name Wegovy or Ozempic when dosed appropriately. PlexusDx compounds from verified, regulated pharmacies and achieves equivalent weight loss, appetite suppression, and metabolic benefits.

How much weight can I expect to lose on semaglutide?

Clinical trials show average weight loss of 10-15% of body weight over 68 weeks when semaglutide 2.4 mg weekly is combined with diet and exercise. Individual results range from 5% to 22% depending on baseline weight, genetics, adherence, and lifestyle changes.

Why does PlexusDx charge a flat monthly fee instead of a flat per-compound pricing?

PlexusDx's flat-rate model ensures transparency and affordability as your dose increases over time. Your dose may need to go up—your price won't. This removes barriers to reaching therapeutic doses and simplifies budgeting compared to brand-name tiered pricing structures.

What are the most common side effects of semaglutide?

Nausea, vomiting, diarrhea, and constipation occur in 20-40% of users, typically mild to moderate and often subsiding by week 4-6. Rare but serious risks include pancreatitis and gallbladder disease. PlexusDx telehealth providers monitor for adverse effects and adjust dosing or compound formulations if needed.

Can the Precision Peptide Genetic Test predict how well semaglutide will work for me?

Yes. PlexusDx maps 14 pathways and 150+ genetic insights including your GLP1R rs6923761 and GIPR rs1800437 variants. These genetic markers correlate with semaglutide response strength and help providers optimize your starting dose and escalation timeline. The test costs $99 and is available after your first month of treatment.

Does Wegovy Work as Well as Ozempic? A Deep Dive into Semaglutide for Effective Weight Management